G

Grand Pharmaceutical Group Ltd
HKEX:512

Watchlist Manager
Grand Pharmaceutical Group Ltd
HKEX:512
Watchlist
Price: 4.74 HKD
Market Cap: 16.8B HKD
Have any thoughts about
Grand Pharmaceutical Group Ltd?
Write Note

Intrinsic Value

The intrinsic value of one Grand Pharmaceutical Group Ltd stock under the Base Case scenario is 4.75 HKD. Compared to the current market price of 4.74 HKD, Grand Pharmaceutical Group Ltd is Fairly Valued.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
4.75 HKD
Fairly Valued
Intrinsic Value
Price
G
Worst Case
Base Case
Best Case

Valuation History
Grand Pharmaceutical Group Ltd

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Grand Pharmaceutical Group Ltd
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for Grand Pharmaceutical Group Ltd cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about Grand Pharmaceutical Group Ltd?
Bearish
Neutral
Bullish

Fundamental Analysis

4.74 HKD
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Grand Pharmaceutical Group Ltd
HK
Pharmaceuticals
Market Cap
16.8B HKD
IPO
Dec 19, 1995
Employees
9 161
Hong Kong
Market Cap
16.8B HKD
Industry
Pharmaceuticals
IPO
Dec 19, 1995
Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Grand Pharmaceutical Group Ltd

Provide an overview of the primary business activities
of Grand Pharmaceutical Group Ltd.

What unique competitive advantages
does Grand Pharmaceutical Group Ltd hold over its rivals?

What risks and challenges
does Grand Pharmaceutical Group Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Grand Pharmaceutical Group Ltd.

Provide P/S
for Grand Pharmaceutical Group Ltd.

Provide P/E
for Grand Pharmaceutical Group Ltd.

Provide P/OCF
for Grand Pharmaceutical Group Ltd.

Provide P/FCFE
for Grand Pharmaceutical Group Ltd.

Provide P/B
for Grand Pharmaceutical Group Ltd.

Provide EV/S
for Grand Pharmaceutical Group Ltd.

Provide EV/GP
for Grand Pharmaceutical Group Ltd.

Provide EV/EBITDA
for Grand Pharmaceutical Group Ltd.

Provide EV/EBIT
for Grand Pharmaceutical Group Ltd.

Provide EV/OCF
for Grand Pharmaceutical Group Ltd.

Provide EV/FCFF
for Grand Pharmaceutical Group Ltd.

Provide EV/IC
for Grand Pharmaceutical Group Ltd.

Show me price targets
for Grand Pharmaceutical Group Ltd made by professional analysts.

What are the Revenue projections
for Grand Pharmaceutical Group Ltd?

How accurate were the past Revenue estimates
for Grand Pharmaceutical Group Ltd?

What are the Net Income projections
for Grand Pharmaceutical Group Ltd?

How accurate were the past Net Income estimates
for Grand Pharmaceutical Group Ltd?

What are the EPS projections
for Grand Pharmaceutical Group Ltd?

How accurate were the past EPS estimates
for Grand Pharmaceutical Group Ltd?

What are the EBIT projections
for Grand Pharmaceutical Group Ltd?

How accurate were the past EBIT estimates
for Grand Pharmaceutical Group Ltd?

Compare the revenue forecasts
for Grand Pharmaceutical Group Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Grand Pharmaceutical Group Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Grand Pharmaceutical Group Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Grand Pharmaceutical Group Ltd compared to its peers.

Compare the P/E ratios
of Grand Pharmaceutical Group Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Grand Pharmaceutical Group Ltd with its peers.

Analyze the financial leverage
of Grand Pharmaceutical Group Ltd compared to its main competitors.

Show all profitability ratios
for Grand Pharmaceutical Group Ltd.

Provide ROE
for Grand Pharmaceutical Group Ltd.

Provide ROA
for Grand Pharmaceutical Group Ltd.

Provide ROIC
for Grand Pharmaceutical Group Ltd.

Provide ROCE
for Grand Pharmaceutical Group Ltd.

Provide Gross Margin
for Grand Pharmaceutical Group Ltd.

Provide Operating Margin
for Grand Pharmaceutical Group Ltd.

Provide Net Margin
for Grand Pharmaceutical Group Ltd.

Provide FCF Margin
for Grand Pharmaceutical Group Ltd.

Show all solvency ratios
for Grand Pharmaceutical Group Ltd.

Provide D/E Ratio
for Grand Pharmaceutical Group Ltd.

Provide D/A Ratio
for Grand Pharmaceutical Group Ltd.

Provide Interest Coverage Ratio
for Grand Pharmaceutical Group Ltd.

Provide Altman Z-Score Ratio
for Grand Pharmaceutical Group Ltd.

Provide Quick Ratio
for Grand Pharmaceutical Group Ltd.

Provide Current Ratio
for Grand Pharmaceutical Group Ltd.

Provide Cash Ratio
for Grand Pharmaceutical Group Ltd.

What is the historical Revenue growth
over the last 5 years for Grand Pharmaceutical Group Ltd?

What is the historical Net Income growth
over the last 5 years for Grand Pharmaceutical Group Ltd?

What is the current Free Cash Flow
of Grand Pharmaceutical Group Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Grand Pharmaceutical Group Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Grand Pharmaceutical Group Ltd

Current Assets 8.2B
Cash & Short-Term Investments 2.3B
Receivables 4.6B
Other Current Assets 1.3B
Non-Current Assets 16.7B
Long-Term Investments 8.4B
PP&E 4B
Intangibles 3.3B
Other Non-Current Assets 892m
Current Liabilities 6.4B
Accounts Payable 3.5B
Short-Term Debt 26m
Other Current Liabilities 2.9B
Non-Current Liabilities 2.8B
Long-Term Debt 2.1B
Other Non-Current Liabilities 712.8m
Efficiency

Earnings Waterfall
Grand Pharmaceutical Group Ltd

Revenue
10.6B HKD
Cost of Revenue
-4.3B HKD
Gross Profit
6.2B HKD
Operating Expenses
-3.5B HKD
Operating Income
2.7B HKD
Other Expenses
-326.7m HKD
Net Income
2.4B HKD

Free Cash Flow Analysis
Grand Pharmaceutical Group Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Grand Pharmaceutical Group Ltd's profitability score is 62/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive Operating Income
Positive Net Income
62/100
Profitability
Score

Grand Pharmaceutical Group Ltd's profitability score is 62/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Grand Pharmaceutical Group Ltd's solvency score is 66/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
High Interest Coverage
Negative Net Debt
66/100
Solvency
Score

Grand Pharmaceutical Group Ltd's solvency score is 66/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Grand Pharmaceutical Group Ltd

Wall Street analysts forecast Grand Pharmaceutical Group Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Grand Pharmaceutical Group Ltd is 5.92 HKD with a low forecast of 5.45 HKD and a high forecast of 6.51 HKD.

Lowest
Price Target
5.45 HKD
15% Upside
Average
Price Target
5.92 HKD
25% Upside
Highest
Price Target
6.51 HKD
37% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Grand Pharmaceutical Group Ltd?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Grand Pharmaceutical Group Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

See Also

Discover More
What is the Intrinsic Value of one Grand Pharmaceutical Group Ltd stock?

The intrinsic value of one Grand Pharmaceutical Group Ltd stock under the Base Case scenario is 4.75 HKD.

Is Grand Pharmaceutical Group Ltd stock undervalued or overvalued?

Compared to the current market price of 4.74 HKD, Grand Pharmaceutical Group Ltd is Fairly Valued.

Back to Top